Deaths in Brazil raise concerns about India’s dengue vaccine, DengiAll
Brazil has suspended the use of the Butantan-DV vaccine following reports of two deaths and several adverse reactions.
🌍 Cross-language spread
This story first appeared in 🇧🇷 Portuguese coverage — 58 minutes before PULSE detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Health authorities in Brazil have temporarily discontinued the use of the Butantan-DV dengue vaccine. This action follows reports of two deaths and numerous cases presenting with warning signs after administration of the vaccine. Consequently, officials have initiated a recall of specific batches currently in circulation.
Coverage from The Star, The Hindu, and Valor International highlights the suspension and the resulting investigation. Anvisa is establishing a panel of experts to conduct an epidemiological review of the occurrences, according to official reports from the Brazilian government. Insights IAS and Outbreak News Today indicate that the development has prompted international scrutiny regarding regional dengue immunization efforts.
Future developments will depend on the findings of the expert panel formed by Anvisa. The investigation is tasked with determining the nature of the reported reactions and the safety profile of the Butantan-DV vaccine. Coverage does not yet specify when the suspension might be lifted or what long-term impact the review will have on vaccination programs.
Synthesized by PULSE from the headlines below under a strict no-invention contract. Updated 152d ago.
Quick answers
Why has the vaccination program been halted?
Brazil suspended the vaccine following reports of two deaths and multiple cases with warning signs after the vaccine was administered.
What is the next step for the vaccine investigation?
Anvisa is organizing a panel of experts to perform an epidemiological investigation into the vaccine and the reported adverse events.
Is the vaccine being removed from circulation?
Yes, officials have suspended the use of the vaccine and initiated a recall of existing batches.
Coverage (7)
- The Dengue Vaccine INSIGHTS IAS · 156d ago
- Anvisa will establish a panel of experts to deepen the epidemiological investigation about the Butantan-DV vaccine www.gov.br · 156d ago
- Brazil suspends new dengue vaccine after two suspicious deaths The Star · 156d ago
- Brazil: 2 deaths, dozens of cases with warning signs, prompts temporary discontinuation of the current Butantan-DV vaccine Outbreak News Today · 156d ago
- Dengue vaccine suspended in Brazil amid investigations into two deaths and serious reactions La Milano · 156d ago
- Brazil suspends Butantan dengue vaccine, recalls batches Valor International · 156d ago
- Deaths in Brazil raise concerns about India’s dengue vaccine, DengiAll The Hindu · 156d ago
Topics
Related trends
Vinicius speaks after scoring hat-trick with Brazil
Vinicius Junior scores first-half hat-trick as Brazil rout Singapore 7-0 in friendly, then pledges to carry form back to Real Madrid.
More people are getting the flu. Should you get a flu shot before you travel?
Multiple U.S. outlets publish coordinated flu-shot guidance as seasonal influenza activity rises ahead of holiday travel.
Possible measles case in North Carolina child prompts public exposure warning
North Carolina health officials investigate a possible measles case in a Catawba County child while warning of public exposures at a Hickory church and pediatric clinic.
The Virus That Makes Your Immune System Forget
Measles remains a highly contagious and potentially deadly disease, with an estimated 95,000 deaths in 2024, mostly children under five, despite a safe and inexpensive vaccine.
CDC declined to alert risk of measles in pregnancy. A journal released the data.
CDC withheld pregnancy measles risk alert while a medical journal published data showing at least 167 infected pregnant Americans since 2025.
US braces for loss of measles elimination status amid worst outbreak in decades
The United States has officially lost its measles elimination status after a 26-year run, marking a historic setback for American public health as outbreaks surge nationwide.